Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000829815 | SCV000971547 | benign | not provided | 2018-06-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000020143 | SCV001159413 | benign | Deficiency of guanidinoacetate methyltransferase | 2018-12-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000020143 | SCV001761401 | benign | Deficiency of guanidinoacetate methyltransferase | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004597730 | SCV005091723 | benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 31% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 29. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000829815 | SCV005308903 | benign | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000020143 | SCV000040469 | not provided | Deficiency of guanidinoacetate methyltransferase | no assertion provided | literature only |